Private Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Private Capital Group's PFE Position: Q2 2022 in Review
Private Capital Group reduced its Pfizer (PFE) stake by 52% in Q2 2022, selling an estimated $459K and leaving 8,226 shares worth $431K. The position accounts for 0.32% of the portfolio, ranked #49.
Private Capital Group first reported a position in PFE in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.38M in Q1 2019. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.
- Private Capital Group held 8,226 shares of Pfizer worth $431K as of Q2 2022.
- Private Capital Group sold 9,014 Pfizer shares in Q2 2022, an estimated $459K.
- Pfizer made up 0.32% of Private Capital Group's portfolio in Q2 2022, its #49 holding.
- Private Capital Group first reported a position in Pfizer in Q4 2017 and has held it in 19 quarters since.
- Private Capital Group's Pfizer position peaked at $1.38M in Q1 2019.
- 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.
Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.